Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,121 across all filing types
Latest filing 2012-11-12 Capital/Financing Update
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Appendix 3B 8 pages 341.4KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to a new issue of securities, application for quotation of additional securities, and agreement with the ASX (Australian Securities Exchange). It details the class and number of securities issued, issue price, purpose of the issue, and other related information about the capital raising and securities quotation. The document is a regulatory announcement about capital raising and securities issuance rather than a full financial report or earnings release. It fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2012-11-12 English
Change of Director's Interest Notice x3 8 pages 47.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by company directors, including number of shares held before and after the change, nature of the interest, and consideration paid. The document is a formal notification of personal share transactions by company directors. It does not contain financial performance data, earnings, or management discussion, but rather reports insider transactions. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is over 11,000 characters, indicating it is a full notice rather than a brief announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2012-11-12 English
Change in substantial holding 2 pages 174.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, specifically a "Notice of change of interests of substantial holder." It details changes in voting power and relevant interests of a substantial shareholder, Mr. Bruce Mathieson, including dates, share quantities, and nature of changes such as placements. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes.
2012-11-12 English
2012 AGM Chairman's Speech 3 pages 141.0KB
AGM Information Classification · 95% confidence The document is a transcript or text of the Annual General Meeting (AGM) of Mayne Pharma held on 9 November 2012. It includes the Chairman's address, introduction of board members and executives, a business update, financial highlights for the fiscal year ended 30 June 2012, and details about a major acquisition and capital raising. The content is focused on the meeting proceedings and presentations made during the AGM rather than a formal annual report or financial statements. The presence of agenda items, voting procedures, and shareholder communications confirms this is AGM material. Therefore, the document fits the category of AGM Information (AGM-R). The document length (8918 characters) and detailed content support this classification with high confidence.
2012-11-08 English
2012 AGM CEO's Speech 5 pages 148.7KB
AGM Information Classification · 95% confidence The document is a detailed speech given at an Annual General Meeting (AGM) of Mayne Pharma, as indicated by the header 'ANNUAL GENERAL MEETING' and the CEO's address. The content includes updates on business operations, acquisitions, product pipelines, and strategic plans, which are typical of presentations or materials shared during an AGM. There is no indication that this is a full annual report, audit report, or earnings release. The length (15,000 characters) and detailed nature support it being AGM materials rather than a brief announcement or regulatory filing. Therefore, the document fits best under the category of AGM Information (AGM-R).
2012-11-08 English
Results of Meeting 4 pages 130.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'RESULTS OF 2012 ANNUAL GENERAL MEETING' and contains detailed voting results for multiple resolutions passed at the AGM, including re-election of directors, approval of remuneration report, and share placements. It references compliance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, which relate to disclosure of voting results. The content is focused on the official announcement of voting outcomes rather than the AGM materials themselves or the full annual report. The document length is about 4848 characters, which is consistent with a detailed voting results announcement. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2012-11-08 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.